Cheng‐Hsiu Lin

1.1k total citations
32 papers, 929 citations indexed

About

Cheng‐Hsiu Lin is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Cheng‐Hsiu Lin has authored 32 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Pharmacology. Recurrent topics in Cheng‐Hsiu Lin's work include Metabolism, Diabetes, and Cancer (14 papers), Natural Antidiabetic Agents Studies (10 papers) and Adipose Tissue and Metabolism (7 papers). Cheng‐Hsiu Lin is often cited by papers focused on Metabolism, Diabetes, and Cancer (14 papers), Natural Antidiabetic Agents Studies (10 papers) and Adipose Tissue and Metabolism (7 papers). Cheng‐Hsiu Lin collaborates with scholars based in Taiwan, South Korea and United States. Cheng‐Hsiu Lin's co-authors include Chun‐Ching Shih, Yueh‐Hsiung Kuo, Jin‐Bin Wu, Weili Lin, Hui‐Ya Ho, Kuo‐Feng Hua, Hsiao‐Wen Chiu, Chen‐Lung Ho, Shih‐Hsiung Wu and Shuk‐Man Ka and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Cheng‐Hsiu Lin

32 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng‐Hsiu Lin Taiwan	17	459	292	222	137	132	32	929
Chun‐Ching Shih Taiwan	19	433 0.9×	305 1.0×	278 1.3×	183 1.3×	186 1.4×	35	951
Jorgete Constantin Brazil	20	410 0.9×	225 0.8×	143 0.6×	116 0.8×	108 0.8×	65	1.2k
Antonio Marcus de Andrade Paes Brazil	19	258 0.6×	186 0.6×	225 1.0×	64 0.5×	214 1.6×	40	1.2k
Jiao Guo China	18	443 1.0×	168 0.6×	132 0.6×	130 0.9×	93 0.7×	33	1.0k
Ching‐jang Huang Taiwan	19	348 0.8×	337 1.2×	73 0.3×	89 0.6×	102 0.8×	31	1.0k
Vandana Panda India	16	229 0.5×	250 0.9×	92 0.4×	251 1.8×	215 1.6×	35	1.1k
M. M. Kesavulu India	12	283 0.6×	584 2.0×	76 0.3×	137 1.0×	194 1.5×	26	1.1k
Tae‐Il Jeon South Korea	17	351 0.8×	107 0.4×	139 0.6×	116 0.8×	106 0.8×	33	986
Yaoyao Jia South Korea	21	416 0.9×	162 0.6×	83 0.4×	91 0.7×	112 0.8×	29	1.0k
Hoda M. Eid Canada	17	548 1.2×	297 1.0×	55 0.2×	94 0.7×	142 1.1×	27	1.1k

Countries citing papers authored by Cheng‐Hsiu Lin

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Hsiu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hsiu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hsiu Lin more than expected).

Fields of papers citing papers by Cheng‐Hsiu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Hsiu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hsiu Lin. The network helps show where Cheng‐Hsiu Lin may publish in the future.

Co-authorship network of co-authors of Cheng‐Hsiu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Hsiu Lin. A scholar is included among the top collaborators of Cheng‐Hsiu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Hsiu Lin. Cheng‐Hsiu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Cheng‐Hsiu, et al.. (2024). Antidiabetic and Antihyperlipidemic Activities and Molecular Mechanisms of Phyllanthus emblica L. Extract in Mice on a High-Fat Diet. Current Issues in Molecular Biology. 46(9). 10492–10529. 2 indexed citations

Lin, Cheng‐Hsiu, Yueh‐Hsiung Kuo, & Chun‐Ching Shih. (2023). Antidiabetic and Immunoregulatory Activities of Extract of Phyllanthus emblica L. in NOD with Spontaneous and Cyclophosphamide-Accelerated Diabetic Mice. International Journal of Molecular Sciences. 24(12). 9922–9922. 8 indexed citations

Lin, Cheng‐Hsiu, et al.. (2023). Antidiabetic and antihyperlipidemic activities of Phyllanthus emblica L. extract in vitro and the regulation of Akt phosphorylation, gluconeogenesis, and peroxisome proliferator-activated receptor α in streptozotocin-induced diabetic mice. Food & Nutrition Research. 67. 9 indexed citations

Lin, Cheng‐Hsiu, et al.. (2019). Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from Antrodia camphorata, in Streptozotocin-Induced Diabetic Mice. International Journal of Molecular Sciences. 20(19). 4897–4897. 20 indexed citations

Lin, Cheng‐Hsiu, et al.. (2017). (−)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice. PLoS ONE. 12(3). e0173984–e0173984. 22 indexed citations

Lin, Cheng‐Hsiu, Yueh‐Hsiung Kuo, & Chun‐Ching Shih. (2017). Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice. International Journal of Molecular Sciences. 18(11). 2314–2314. 27 indexed citations

Kuo, Yueh‐Hsiung, Cheng‐Hsiu Lin, Chun‐Ching Shih, & Chang-Syun Yang. (2016). Antcin K, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects via Glucose Transporter 4 and AMP‐Activated Protein Kinase Phosphorylation in Muscles. Evidence-based Complementary and Alternative Medicine. 2016(1). 4867092–4867092. 25 indexed citations

Kuo, Yueh‐Hsiung, Cheng‐Hsiu Lin, & Chun‐Ching Shih. (2015). Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, fromAntrodia camphoratain Vitro and in Streptozotocin-Induced Mice. Journal of Agricultural and Food Chemistry. 63(46). 10140–10151. 46 indexed citations

Chao, Louis Kuoping, Cheng‐Hsiu Lin, Huan-Wen Chiu, et al.. (2015). Peroxyauraptenol Inhibits Inflammation and NLRP3 Inflammasome Activation by Inhibiting Reactive Oxygen Species Generation and Preserving Mitochondrial Integrity. Journal of Agricultural and Food Chemistry. 63(4). 1210–1219. 27 indexed citations

10.

Kuo, Yueh‐Hsiung, Cheng‐Hsiu Lin, & Chun‐Ching Shih. (2014). Caffeamide 36‐13 Regulates the Antidiabetic and Hypolipidemic Signs of High‐Fat‐Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production. Evidence-based Complementary and Alternative Medicine. 2014(1). 821569–821569. 10 indexed citations

11.

Shih, Chun‐Ching, et al.. (2014). Validation of the Antidiabetic and Hypolipidemic Effects ofClitocybe nudaby Assessment of Glucose Transporter 4 and Gluconeogenesis and AMPK Phosphorylation in Streptozotocin‐Induced Mice. Evidence-based Complementary and Alternative Medicine. 2014(1). 705636–705636. 15 indexed citations

12.

Wu, Jin‐Bin, Yueh‐Hsiung Kuo, Cheng‐Hsiu Lin, Hui‐Ya Ho, & Chun‐Ching Shih. (2014). Tormentic Acid, a Major Component of Suspension Cells of Eriobotrya japonica, Suppresses High-Fat Diet-Induced Diabetes and Hyperlipidemia by Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation. Journal of Agricultural and Food Chemistry. 62(44). 10717–10726. 43 indexed citations

13.

Hua, Kuo‐Feng, Ju‐Ching Chou, Shuk‐Man Ka, et al.. (2014). Cyclooxygenase‐2 Regulates NLRP3 Inflammasome‐Derived IL‐1β Production. Journal of Cellular Physiology. 230(4). 863–874. 110 indexed citations

14.

Shih, Chun‐Ching, et al.. (2013). Cell Suspension Culture of Eriobotrya japonica Regulates the Diabetic and Hyperlipidemic Signs of High-Fat-Fed Mice. Molecules. 18(3). 2726–2753. 34 indexed citations

15.

Shih, Chun‐Ching, Cheng‐Hsiu Lin, & Jin‐Bin Wu. (2010). Eriobotrya japonica improves hyperlipidemia and reverses insulin resistance in high‐fat‐fed mice. Phytotherapy Research. 24(12). 1769–1780. 52 indexed citations

16.

Hsieh, Ming‐Hong, Wei‐Wen Lin, Nan‐Ying Chiu, et al.. (2010). A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. Annals of General Psychiatry. 9(1). 35–35. 15 indexed citations

17.

Shih, Chun‐Ching, Cheng‐Hsiu Lin, Weili Lin, & Jin‐Bin Wu. (2009). Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. Journal of Ethnopharmacology. 123(1). 82–90. 111 indexed citations

18.

Shih, Chun‐Ching, Cheng‐Hsiu Lin, & Weili Lin. (2009). Ameliorative effects of Vaccaria segetalis extract on osteopenia in ovariectomized rats. Journal of Natural Medicines. 63(4). 386–392. 10 indexed citations

19.

Shih, Chun‐Ching, Cheng‐Hsiu Lin, & Weili Lin. (2008). Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet. Diabetes Research and Clinical Practice. 81(2). 134–143. 103 indexed citations

20.

Chen, I‐Chun, et al.. (2007). How Effectively Do Parents Discern Their Children's Cognitive Deficits at a Preschool Age?. Journal of the Chinese Medical Association. 70(10). 445–450. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact